HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiyoto Nishi Selected Research

Metalloendopeptidases (Metalloendopeptidase)

1/2019Serum Nardilysin, a Surrogate Marker for Epithelial-Mesenchymal Transition, Predicts Prognosis of Intrahepatic Cholangiocarcinoma after Surgical Resection.
1/2018Nardilysin controls intestinal tumorigenesis through HDAC1/p53-dependent transcriptional regulation.
9/2017Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiyoto Nishi Research Topics

Disease

5Heart Failure
05/2012 - 05/2007
3Neoplasms (Cancer)
01/2021 - 05/2017
2Obesity
01/2022 - 01/2020
2Diabetes Mellitus
01/2020 - 10/2009
2Inflammation (Inflammations)
10/2019 - 01/2019
2Myocardial Ischemia (Ischemic Heart Diseases)
09/2017 - 10/2009
2Necrosis
09/2017 - 01/2017
2Cardiovascular Diseases (Cardiovascular Disease)
07/2010 - 10/2009
1Body Weight (Weight, Body)
01/2022
1Weight Loss (Weight Reduction)
01/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Bradycardia
01/2020
1Cardiomyopathies (Cardiomyopathy)
01/2020
1Hypotension (Low Blood Pressure)
01/2020
1Myocarditis (Carditis)
10/2019
1Cholangiocarcinoma
01/2019
1Pancreatitis
01/2019
1Adenocarcinoma
01/2019
1Carcinogenesis
01/2018
1Acute Coronary Syndrome
09/2017
1Unstable Angina
09/2017
1Myocardial Infarction
09/2017
1Hepatocellular Carcinoma (Hepatoma)
05/2017
1Hepatitis C
05/2017
1Arthritis (Polyarthritis)
01/2017
1Type 2 Diabetes Mellitus (MODY)
10/2016
1Alzheimer Disease (Alzheimer's Disease)
01/2014
1Amyloid Plaque
01/2014
1Death (Near-Death Experience)
05/2007

Drug/Important Bio-Agent (IBA)

9nardilysinIBA
01/2021 - 01/2014
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 10/2016
3Metalloendopeptidases (Metalloendopeptidase)IBA
01/2019 - 09/2017
3Biomarkers (Surrogate Marker)IBA
01/2019 - 10/2009
3human NPPA protein (carperitide)IBA
05/2012 - 05/2007
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2014
2Natriuretic PeptidesIBA
05/2012 - 05/2007
2TroponinIBA
07/2010 - 07/2007
1TamoxifenFDA LinkGeneric
01/2022
1Sodium-Glucose Transporter 1IBA
01/2022
1PalmitatesIBA
01/2020
1Fatty Acids (Saturated Fatty Acids)IBA
01/2020
1Acetyl-CoA CarboxylaseIBA
01/2020
1Insulin (Novolin)FDA Link
10/2019
1GemcitabineFDA Link
01/2019
1AntigensIBA
09/2017
1AutoantibodiesIBA
09/2017
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
05/2017
1CollagenIBA
01/2017
1Amyloid (Amyloid Fibrils)IBA
01/2014
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2014
1Peptides (Polypeptides)IBA
01/2014
1Amyloid beta-PeptidesIBA
01/2014
1NitratesIBA
07/2010
1Atrial Natriuretic Factor (ANF)IBA
07/2010
1Troponin IIBA
07/2010
1Troponin T (Troponin T1)IBA
10/2009
1CreatinineIBA
10/2009
1Brain Natriuretic Peptide (Natrecor)FDA Link
10/2009
1trans-crotonin (CTN)IBA
07/2007
1olprinoneIBA
05/2007
1Pharmaceutical PreparationsIBA
05/2007
1Dopamine (Intropin)FDA LinkGeneric
05/2007
1DobutamineFDA LinkGeneric
05/2007
1Phosphodiesterase InhibitorsIBA
05/2007
1CatecholaminesIBA
05/2007

Therapy/Procedure

1Hepatectomy
05/2017
1Therapeutics
05/2007